Patents Assigned to Sovereign Pharmaceuticals, LLC
-
Patent number: 10105324Abstract: Disclosed is a method of treating or ameliorating a condition which can be treated or ameliorated by the administration of guaifenesin, which method comprises orally administering to a subject in need thereof an effective amount of an immediate release solution for oral administration of guaifenesin and at least one additional drug. In addition to water the solution comprises as solvents propylene glycol and glycerol in a concentration which significantly increases the bioavailability of guaifenesin in the human body.Type: GrantFiled: October 30, 2017Date of Patent: October 23, 2018Assignee: SOVEREIGN PHARMACEUTICALS, LLCInventor: Paul Hafey
-
Patent number: 10098856Abstract: A combination of dosage units for alleviating respiratory ailments and a method of alleviating respiratory ailments which uses this combination of dosage units. The dosage units comprise one or more first dosage units comprising pseudoephedrine and/or a pharmaceutically acceptable salt thereof and one or more second dosage units comprising phenylephrine and/or a pharmaceutically acceptable salt thereof.Type: GrantFiled: June 2, 2016Date of Patent: October 16, 2018Assignee: Sovereign Pharmaceuticals, LLCInventors: Suresh Dixit, Juan Carlos Menendez, Ralph Brown
-
Patent number: 9844538Abstract: A method of alleviating or treating a condition which can be alleviated or treated by administering hyoscyamine comprises administering to a subject in need thereof a pharmaceutical dosage form which comprises at least one of hyoscyamine and a pharmaceutically acceptable salt thereof. The dosage form comprises two or more hyoscyamine formulations, at least one of the formulations being an immediate release formulation and at least one other one being a controlled release formulation.Type: GrantFiled: April 1, 2016Date of Patent: December 19, 2017Assignee: Sovereign Pharmaceuticals, LLCInventors: Viswanathan Srinivasan, Ralph Brown, David Brown, Himanshu Patel, Juan Carlos Menendez, Somphet Peter Suphasawud
-
Patent number: 9808431Abstract: Disclosed is an immediate release solution for oral administration of guaifenesin and at least one additional drug. In addition to water the solution comprises as solvents propylene glycol and glycerol in a concentration which significantly increases the bioavailability of guaifenesin in the human body.Type: GrantFiled: January 9, 2017Date of Patent: November 7, 2017Assignee: Sovereign Pharmaceuticals, LLCInventor: Paul Hafey
-
Patent number: 9592197Abstract: A pharmaceutical dosage form which comprises diphenhydramine and/or a pharmaceutically acceptable salt thereof and at least one second drug. The dosage form provides a plasma concentration within the therapeutic range of the at least one second drug over a period which is coextensive with a substantial part of the period over which the dosage form provides a plasma concentration within the therapeutic range of diphenhydramine or salt thereof. This Abstract is neither intended to define the invention disclosed in this specification nor intended to limit the scope of the invention in any way.Type: GrantFiled: December 16, 2004Date of Patent: March 14, 2017Assignee: SOVEREIGN PHARMACEUTICALS, LLCInventors: Viswanathan Srinivasan, Juan Carlos Menendez, Venkatesh Balasubramanian, Somphet Peter Suphasawud, Ralph Brown, David Brown
-
Patent number: 9549907Abstract: Disclosed is an immediate release solution for oral administration of guaifenesin and at least one additional drug. In addition to water the solution comprises as solvents propylene glycol and glycerol in a concentration which significantly increases the bioavailability of guaifenesin in the human body.Type: GrantFiled: November 13, 2015Date of Patent: January 24, 2017Assignee: SOVEREIGN PHARMACEUTICALS, LLCInventor: Paul Hafey
-
Patent number: 9492541Abstract: A pharmaceutical dosage form which comprises phenylepherine or a pharmaceutically acceptable salt thereof and a second drug. The dosage form provides a plasma concentration within the therapeutic range of the second drug over a period which is coextensive with at least about 70% of the period over which the dosage form provides a plasma concentration within the therapeutic range of phenylepherine. This abstract is neither intended to define the invention disclosed in this specification nor intended to limit the scope of the invention in any way.Type: GrantFiled: September 14, 2004Date of Patent: November 15, 2016Assignee: SOVEREIGN PHARMACEUTICALS, LLCInventors: Viswanathan Srinivasan, Ralph Brown, David Brown, Juan Carlos Menendez, Venkatesh Balasubramanian, Somphet Peter Suphasawud
-
Patent number: 9364451Abstract: A combination of dosage units for alleviating respiratory ailments and a method of alleviating respiratory ailments which uses this combination of dosage units. The dosage units comprise one or more first dosage units comprising pseudoephedrine and/or a pharmaceutically acceptable salt thereof and one or more second dosage units comprising phenylephrine and/or a pharmaceutically acceptable salt thereof.Type: GrantFiled: January 7, 2014Date of Patent: June 14, 2016Assignee: Sovereign Pharmaceuticals, LLCInventors: Suresh Dixit, Juan Carlos Menendez, Ralph Brown
-
Patent number: 9308164Abstract: A pharmaceutical dosage form which comprises two or more different hyoscyamine formulations, at least one of the formulations being an immediate release hyoscyamine formulation and at least one other one being a controlled release hyoscyamine formulation. This abstract is neither intended to define the invention disclosed in this specification nor intended to limit the scope of the invention in any way.Type: GrantFiled: June 30, 2004Date of Patent: April 12, 2016Assignee: Sovereign Pharmaceuticals, LLCInventors: Viswanathan Srinivasan, Ralph Brown, David Brown, Himanshu Patel, Juan Carlos Menendez, Somphet Peter Suphasawud
-
Patent number: 8653135Abstract: A combination of dosage units for alleviating respiratory ailments and a method of alleviating respiratory ailments which uses this combination of dosage units. The dosage units comprise one or more first dosage units comprising pseudoephedrine and/or a pharmaceutically acceptable salt thereof and one or more second dosage units comprising phenylephrine and/or a pharmaceutically acceptable salt thereof. This Abstract is neither intended to define the invention disclosed in this specification nor intended to limit the scope of the invention in any way.Type: GrantFiled: February 7, 2007Date of Patent: February 18, 2014Assignee: Sovereign Pharmaceuticals, LLCInventors: Suresh Dixit, Juan Carlos Menendez, Ralph Brown